Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

4/6/2014 (10 months ago)

Catholic Online (www.catholic.org)

Drug cut in half the risk that cancer would worsen

An important treatment option in the fight against breast cancer may be waiting in the wings. Researchers say a new type of drug could help prevent advanced breast cancer from worsening. The potential is great for breast cancer patients, and makes for a potential blockbuster product for Pfizer.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

4/6/2014 (10 months ago)

Published in Health

Keywords: Pfizer, breast cancer, palbociclib


LOS ANGELES, CA (Catholic Online) - Said drug cut in half the risk that cancer would worsen, or progress, researchers said. The median time before the disease progressed or the women died was 20.2 months for those who received the drug, compared with 10.2 months for the control group.

"The magnitude of benefit we are seeing is not something commonly seen in cancer medicine studies," Dr. Richard S. Finn, a principal investigator in the study, says. Finn, an oncologist at the University of California, Los Angeles, called the results "quite groundbreaking."

No child need ever go to bed hungry -- Learn how you can help!


Known as palbociclib, the drug also appeared to prolong survival but not by a statistically significant amount. Those who received the drug lived a median of 37.5 months in contrast with 33.3 months for those in the control group.

The results from the Phase 2, or mid-stage, study were presented here at the annual meeting of the American Association for Cancer Research. Palbociclib is considered a jewel in Pfizer's product pipeline, with analysts predicting annual sales of billions of dollars. Amgen is entitled to an eight percent royalty on sales of the drug.

Some investors may have been letdown due to the drug, partly because they were not quite as good as interim results presented about halfway through the trial. At that point, the difference in median progression-free survival was 26.1 months for palbociclib versus 7.5 months for the control group.

Finn stresses that a statistically significant survival benefit should not have been expected at this point because only 61 of the 165 patients in the trial had died. Patients can use other drugs after leaving the trial, which can dilute any effect of palbociclib.

Palbociclib slows the proliferation of cancer cells by inhibiting the activity of two related enzymes involved in cell division; cyclin-dependent kinases 4 and 6.

While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor. While breast cancer is the initial focus, the drugs are being tested for other cancers.

Breast cancer specialists not involved in the study were encouraged -- but expressed caution. "These results are strikingly positive and with a large potential impact to patients," Dr. Jos Baselga said in a speech at the conference discussing the results.

Baselga, the physician in chief at the Memorial Sloan-Kettering Cancer Center, also said the results might have been biased because the study investigators, who determined whether tumors had progressed, knew which patients were getting palbociclib.

Dr. Eric P. Winer, chief of women's cancers at the Dana-Farber Cancer Institute in Boston, says larger studies were still needed.

"This is a small Phase 2 trial - not tiny, but not the kind of study that would typically lead to a change in practice," he said.

---


Pope Francis: end world hunger through 'Prayer and Action'


Copywriter 2015 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for March 2015
Universal:
Scientists: That those involved in scientific research may serve the well-being of the whole human person.
Evangelization: Contribution of women: That the unique contribution of women to the life of the Church may be recognized always.



Comments


More Health

'Smoking is even deadlier than we thought' New study gives alarming statistics for smokers Watch

Image of The Centers for Disease Control and Prevention estimates about 42.1 million Americans smoke cigarettes, a habit which remains the number one cause of preventable disease and death in the U.S.

By Catholic Online (NEWS CONSORTIUM)

Smoking cigars and cigarettes has long been the source of various cancers, such as lung and mouth cancers, and has been linked to heart attack, stroke and high blood pressure. New research from Australian medical examiners have now discovered that the practice ... continue reading


Paging Dr. Frankenstein! Human head transplant possible in just two years Watch

Image of Dr. Sergio Canavero said he would expect the patient to be able to move and feel their face when they awoke, they would speak with the same voice. They would be able to walk within a year.

By Catholic Online (NEWS CONSORTIUM)

The procedure would be beneficial to humankind - and help those who are stricken with devastating disease. When we learn of the process, however, the first thing to pop into our heads is hunchbacked assistants and green-faced monsters. A human heads transplant ... continue reading


Shocking 'medical miracle' birth startles doctors and parents Watch

Image of (Cedars-Sinai Medical Center in Los Angeles)

By Abigail James (NEWS CONSORTIUM)

Now dubbed a "medical miracle," the birth of Silas Philips took doctors by surprise when he was born still inside his amniotic sac. Silas' birth miracle is extremely rare, only 1 in 80,000 births are similar to his. LOS ANGELES, CA (Catholic Online) - When his mother ... continue reading


New pill dramatically cuts risk for AIDS transmission in homosexual men Watch

Image of Some 545 HIV-negative gay men, who were sexually active and had recently had unprotected sex, were recruited to the study.

By Catholic Online (NEWS CONSORTIUM)

A daily pill, pre-exposure prophylaxis, or PrEP has been found to dramatically cut a person's risk of contracting HIV. Following a trial in the United Kingdom, advocates say the drug must be made available as soon as possible. LOS ANGELES, CA (Catholic Online) ... continue reading


AT RISK: Formula-fed babies at risk for ingesting ARSENIC Watch

Image of While arsenic in home tap water was a source of the naturally occurring chemical, poisonous in large doses, the formula itself was a contributing factor as well.

By Catholic Online (NEWS CONSORTIUM)

Breastfeeding has long been deemed the healthiest nursing option for newborns. A new study from Dartmouth College bears this out: According to researchers, arsenic levels were more than seven times higher in formula-fed babies than in breastfed ones. LOS ... continue reading


Unbelievable: Secret to success may lie in your sleeping habits Watch

Image of New studies show the most successful people receive little sleep at night.

By Abigail James (NEWS CONSORTIUM)

Traditional research advises people between 18-64 years old get seven to nine hours of sleep for a healthy lifestyle. New studies are showing that some of the most successful and smartest people in the world rarely even get half of that amount of sleep a night. LOS ... continue reading


Closing door and throwing away the key: HIV vaccine proves SUCCESSFUL in monkeys Watch

Image of Given the drug, the test monkeys were able to fend off high, repeated doses of the simian version of the disease.

By Catholic Online (NEWS CONSORTIUM)

Comparing it to locking up an intruder and throwing away the key, scientists now say they have created an anti-HIV drug so powerful that it could work as a vaccine. The test trials have proven to be highly successful in Macaque monkeys.  LOS ANGELES, CA ... continue reading


Women are at risk: Dementia affects more women than men, quickly becoming number one killer Watch

Image of

By Abigail James (NEWS CONSORTIUM)

500,000 women are affected by dementia. This is compared to the 350,000 men who are afflicted. Dementia is quickly surpassing breast cancer or heart disease; it is becoming the newest disease that favors women. LOS ANGELES, CA (Catholic Online) - Not only is dementia ... continue reading


Unable to feel pain, rare medical condition haunts man's life with horrifying injuries Watch

Image of Undergoing a series of tests throughout his lifetime, it was not until 2011 that Steve Pete was given the genetic tests confirmed he and his brother Chris had genetic mutations of the SCN9A gene.

By Catholic Online (NEWS CONSORTIUM)

Steve Pete's parents knew something was wrong with their child when he chewed part of his tongue off while he was a baby. Pete suffers from a rare condition known as congenital analgesia, where he is unable to feel pain. Unable to detect physical discomfort, ... continue reading


Don't throw away those glasses yet! Lasik eye surgery found imperfect, even dangerous Watch

Image of The results of bad eye laser surgery include the necessitating of several glasses for both near and far-sighted vision, dry eyes and blurring of light sources at night.

By Catholic Online (NEWS CONSORTIUM)

Lasik eye surgery, where vision defects are cured with lasers, has a high success rate. However, anyone who undergoes the procedure must carefully weigh the risks. Those for whom the procedure fails must wear several glasses afterwards and suffer ailments. The ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Psalms 79:8, 9, 11, 13
8 Do not count against us the guilt of former ... Read More

Psalm, Psalms 79:8, 9, 11, 13
13 And we, your people, the flock that you pasture, ... Read More

Gospel, Luke 6:36-38
36 'Be compassionate just as your Father is ... Read More

Saint of the Day

Saint of the Day for March 2nd, 2015 Image

Bl. Charles the Good
March 2: In 1086, St. Canute, King of Denmark and father of Blessed ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter